1-3 of 3
Susan Dubuc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trials in Progress: A Phase 3 Study to Investigate Efficacy, Safety, and Tolerability of Mavorixafor in Participants with Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders

Deborah J. Steiner, Katrina Adell, Henry Wu, Susan Dubuc, Katherine Carter, Nour Ziyadeh, Margo Jaffee, Xiaoxi Li, Sam Wilson, Matthew Dame, Wendy Magnan, Christophe Arbet-Engels
Journal: Blood
Blood (2024) 144 (Supplement 1): 3924.1.
https://doi.org/10.1182/blood-2024-205179
Published: 2024
Journal Articles

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Clinical Trials & Observations
Raffaele Badolato, Laia Alsina, Antoine Azar, Yves Bertrand, Audrey A. Bolyard, David Dale, Àngela Deyà-Martínez, Kathryn E. Dickerson, Navid Ezra, Henrik Hasle, Hyoung Jin Kang, Sorena Kiani-Alikhan, Taco W. Kuijpers, Alexander Kulagin, Daman Langguth, Carina Levin, Olaf Neth, Peter Olbrich, Jane Peake, Yulia Rodina, Caroline E. Rutten, Anna Shcherbina, Teresa K. Tarrant, Matthias G. Vossen, Christian A. Wysocki, Andrea Belschner, Gary J. Bridger, Kelly Chen, Susan Dubuc, Yanping Hu, Honghua Jiang, Sunny Li, Rick MacLeod, Murray Stewart, Arthur G. Taveras, Tina Yan, Jean Donadieu
Journal: Blood
Blood (2024) 144 (1): 35–45.
https://doi.org/10.1182/blood.2023022658
Published: 2024
Includes: Supplemental data
Journal Articles

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing

Julia T. Warren, Kathryn E. Dickerson, Anjali A. Sharathkumar, Jolan E. Walter, David B. Wilson, Katrina P. Adell, Kelly Chen, Susan Dubuc, Rick MacLeod, Katie Peters, Murray Stewart, Arthur G. Taveras, Kelly Walkovich
Journal: Blood
Blood (2023) 142 (Supplement 1): 1160.
https://doi.org/10.1182/blood-2023-173549
Published: 2023